Log in to save to my catalogue

Attenuation of Tobacco Smoke-Induced Lung Inflammation by Treatment with a Soluble Epoxide Hydrolase...

Attenuation of Tobacco Smoke-Induced Lung Inflammation by Treatment with a Soluble Epoxide Hydrolase...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17560351

Attenuation of Tobacco Smoke-Induced Lung Inflammation by Treatment with a Soluble Epoxide Hydrolase Inhibitor

About this item

Full title

Attenuation of Tobacco Smoke-Induced Lung Inflammation by Treatment with a Soluble Epoxide Hydrolase Inhibitor

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2005-02, Vol.102 (6), p.2186-2191

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Changes in the lungs due to smoking include inflammation, epithelial damage, and remodeling of the airways. Airway inflammation is likely to play a critical role in the genesis and progression of tobacco smoke-induced airway disease. Soluble epoxide hydrolase (sEH) is involved in the metabolism of endogenous chemical mediators that play an importan...

Alternative Titles

Full title

Attenuation of Tobacco Smoke-Induced Lung Inflammation by Treatment with a Soluble Epoxide Hydrolase Inhibitor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_17560351

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17560351

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0409591102

How to access this item